Literature DB >> 17468967

Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision.

Michael Schlander1, Oliver Schwarz, Goetz-Erik Trott, Michael Viapiano, Norbert Bonauer.   

Abstract

OBJECTIVE: To determine age and gender specific administrative prevalence of ADHD (hyperkinetic disorder, HKD, and hyperkinetic conduct disorder, HKCD, according to ICD-10-based coding) in Germany in 2003, and to assess physician involvement in medical care.
METHOD: Retrospective claims database analysis covering the insured population of Nordbaden, Germany (n = 2.238 million).
RESULTS: A total of 11,875 subjects with a diagnosis of HKD/HKCD were identified (overall 12-month prevalence rate 0.53%). Prevalence was highest among children age 7-12 years (5.0%; boys, 7.2%; girls, 2.7%). Among adults age 20 years and higher, prevalence was 0.04% (males, 0.04%; females, 0.03%). 36.0% (13.0%) of children and adolescents and 33.5% (12.5%) of adults with a diagnosis of ADHD were seen by a specialized physician at least once (four times) during the year. Physician involvement by discipline was highly skewed.
CONCLUSION: Diagnosis rates in children and adolescents exceeded those expected according to ICD-10 criteria, but matched DSM-IV-based estimates. In the adult population, ADHD was rarely detected. Most patients were not seen by a mental health specialist, and physician involvement was highly concentrated. Potential policy implications include a high need for expertise among pediatricians and general practitioners. The data indicate an urgent need for further research into health care utilization and quality.

Entities:  

Mesh:

Year:  2007        PMID: 17468967     DOI: 10.1007/s00787-007-0616-1

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  30 in total

1.  Foreword -- ADHD in the scientific and political context.

Authors:  Jan K Buitelaar; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

2.  Training raters to assess adult ADHD: reliability of ratings.

Authors:  Lenard A Adler; Thomas Spencer; Stephen V Faraone; Fred W Reimherr; Douglas Kelsey; David Michelson; Joseph Biederman
Journal:  J Atten Disord       Date:  2005-02       Impact factor: 3.256

Review 3.  Clinical practice. Attention deficit-hyperactivity disorder.

Authors:  Marsha D Rappley
Journal:  N Engl J Med       Date:  2005-01-13       Impact factor: 91.245

4.  Provision of child and adolescent psychiatric services in the Federal Republic of Germany.

Authors:  C Höger; A Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  1998-09       Impact factor: 4.785

5.  Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

Authors:  J J Sandra Kooij; Jan K Buitelaar; Edwin J van den Oord; Johan W Furer; Cees A Th Rijnders; Paul P G Hodiamont
Journal:  Psychol Med       Date:  2005-06       Impact factor: 7.723

6.  Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample.

Authors:  M L Wolraich; J N Hannah; T Y Pinnock; A Baumgaertel; J Brown
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-03       Impact factor: 8.829

7.  The boundaries of attention deficit disorder.

Authors:  M A Epstein; S E Shaywitz; B A Shaywitz; J L Woolston
Journal:  J Learn Disabil       Date:  1991-02

Review 8.  Epidemiology of ADHD in school-age children.

Authors:  L Scahill; M Schwab-Stone
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2000-07

9.  Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample.

Authors:  M L Wolraich; J N Hannah; A Baumgaertel; I D Feurer
Journal:  J Dev Behav Pediatr       Date:  1998-06       Impact factor: 2.225

Review 10.  Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

View more
  14 in total

Review 1.  [The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness].

Authors:  M Schlander; G-E Trott; O Schwarz
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

2.  ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.

Authors:  Christian J Bachmann; Alexandra Philipsen; Falk Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2017-03-03       Impact factor: 5.594

3.  The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

Authors:  Ingrid Schubert; Ingrid Köster; Gerd Lehmkuhl
Journal:  Dtsch Arztebl Int       Date:  2010-09-10       Impact factor: 5.594

4.  Anthroposophic therapy for attention deficit hyperactivity: a two-year prospective study in outpatients.

Authors:  Harald J Hamre; Claudia M Witt; Gunver S Kienle; Christoph Meinecke; Anja Glockmann; Renatus Ziegler; Stefan N Willich; Helmut Kiene
Journal:  Int J Gen Med       Date:  2010-08-30

5.  Attention deficit hyperactivity disorder in adulthood: diagnosis, etiology and therapy.

Authors:  Alexandra Philipsen; Bernd Hesslinger; Ludger Tebartz van Elst
Journal:  Dtsch Arztebl Int       Date:  2008-04-25       Impact factor: 5.594

6.  How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study.

Authors:  Manfred Döpfner; Dieter Breuer; Nora Wille; Michael Erhart; Ulrike Ravens-Sieberer
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-12       Impact factor: 4.785

7.  Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective.

Authors:  Juliana Setyawan; Moshe Fridman; Paul Hodgkins; Javier Quintero; M Haim Erder; Božena J Katić; Valerie Harpin
Journal:  Atten Defic Hyperact Disord       Date:  2014-08-23

8.  Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence.

Authors:  Michael Schlander
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2007-11-15       Impact factor: 3.033

9.  Epidemiology of treated attention-deficit/hyperactivity disorder (ADHD) across the lifespan in Taiwan: a nationwide population-based longitudinal study.

Authors:  Charles Lung-Cheng Huang; Chin-Chen Chu; Tain-Junn Cheng; Shih-Feng Weng
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

10.  The proportion of uncoded diagnoses in computerized health insurance claims in Japan in May 2010 according to ICD-10 disease categories.

Authors:  Shinichi Tanihara
Journal:  J Epidemiol       Date:  2014-06-28       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.